Average Co-Inventor Count = 5.63
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Astrazeneca Ab (12 from 1,500 patents)
2. Albireo Ab (1 from 57 patents)
13 patents:
1. 12024523 - Pyrazole derivatives useful as 5-lipoxygenase activating protein (FLAP) inhibitors
2. 11691978 - Pyrazole derivatives useful as 5-lipoxygenase activating protein (FLAP) inhibitors
3. 11001589 - Pyrazole derivatives useful as 5-lipoxygenase activating protein (FLAP) inhibitors
4. 10508119 - Pyrazole derivatives useful as 5-lipdxygenase activating protein (FLAP) inhibitors
5. 10183947 - Pyrazole derivatives useful as 5-lipoxygenase activating protein (FLAP) inhibitors
6. 8067584 - Benzothiazepine derivatives
7. 7893048 - 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions
8. 7871998 - Diphenylazetidinone derivatives possessing cholesterol absorption inhibitory activity
9. 7863265 - 2-azetidinone derivatives and their use as cholesterol absorption inhibitors for the treatment of hyperlipidaemia
10. 7842684 - Diphenylazetidinone derivatives possessing cholesterol absorption inhibitor activity
11. 7470678 - Diphenylazetidinone derivatives for treating disorders of the lipid metabolism
12. 7192947 - Peptides derivatives comprising thiazepine group for the treatment of hyperlipidemic conditions
13. 7132416 - Benzothiazepine and benzothiazepine derivatives with ileal bile acid transport (IBAT) inhibotory activity for the treatment hyperlipidaemia